期刊文献+

辛伐他汀治疗煤工尘肺肺动脉高压患者的临床观察 被引量:2

Clinical study on simvastatin treatment of pulmonary hypertension in patients with coal worker's pneumoconiosis
原文传递
导出
摘要 目的探讨辛伐他汀治疗煤工尘肺肺动脉高压的疗效。方法选择煤工尘肺肺动脉高压患者96例,随机分为治疗组(48例)和对照组(48例)。对照组口服华法林2.5mg,每天1次,共4个月;治疗组口服辛伐他汀20mg,每晚1次,共4个月。治疗前后进行6min步行试验及以超声心动图测肺动脉压力。结果治疗组治疗后6min步行距离为(258±26)m,与治疗前[(225±19)m]及对照组治疗后[(240±20)m]比较,差异均有统计学意义(P〈0.05,P〈0.01)。治疗组治疗后肺动脉压力为(36±3)mm№,较治疗前[(41±9)mmHg]及对照组治疗后[(39±5)mmHg]明显降低,差异有统计学意义(P〈0.05)。结论辛伐他汀能改善煤工尘肺肺动脉高压,疗效确切。 Objective To observe simvastatin treatment of pulmonary hypertension in patients with coal workers pneumoconiosis (CWP). Methods 96 CWP patients with pulmonary hypertension were randomly divided into treatment and control groups. The control group was treated with 2.5 mg warfarin, once a day for four months; the treatment group was treated with 20 mg simvastatin, taken in evening, for 4 months. 6 min walking distance (6MWD) test and inspection pulmonary artery pressure were measured by echocardiography before and after treatment. Results In the treatment group, the 6MWD were (258±26)m after treatment and (225±19)m before treatment, respectively. Compared with control group, pulmonary artery pressure was (41±9)mm Hg in the treatment group before treatment, (36±3)mm Hg in the treatment group after treatment, and(39±5 )mm Hg in control group, respectively, the diffrence was statistically significant(P〈 0.05). Conclusions Simvastatin can improve pulmonary hypertension in coal workers pneumoconiosis, and shows a definite curative effect.
出处 《中华劳动卫生职业病杂志》 CAS CSCD 北大核心 2011年第3期230-231,共2页 Chinese Journal of Industrial Hygiene and Occupational Diseases
关键词 斯伐他汀 尘肺 肺动脉 压力 Simvastatin Pneumoeoniosis Pulmonary artery Pressure
  • 相关文献

参考文献9

  • 1赵亮,周同甫.辛伐他汀与肺动脉高压[J].心血管病学进展,2006,27(1):73-76. 被引量:13
  • 2蔡极蔷.呼吸内科学.北京:中国协和医科大学出版社,2000:480.
  • 3张萍.6分钟步行试验[J].临床心电学杂志,2007,16(3):236-237. 被引量:58
  • 4Gingis RE,LiD,Zhan X,et al Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Heart Circ Physiol,2003,285:H938-945.
  • 5Kao PN. Simvastatin treatment of pulmonary hypertension: an observational case series.Chest,2005,127:1446-1452.
  • 6Takemoto M, Liao JK. Pleiotropie effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.Arterioscler Thromb Vasc Biol, 2001,21:1712-1719.
  • 7Ruhib LJ.Therapy of pulmonary hypertension: the evolution from vasodilators to antiproliferative agents.Am J Respir Crit Care Med, 2002,166:1308-1309.
  • 8Martlnz-Gonzalez J, Escudero I, Badimon L.Simvastatin potenciates PGI (2)release induced by HDL in human VSMC:effect Cox-2 upregulation and MAPK signalling pathways activated by HDL. Atherosclerosis,2004,174:305 -313.
  • 9李兰菊,岳红卫,魏一平,梁瑞芳,段丽铭,宋丽丽,周健,李延玲.辛伐他汀联合磷酸川芎嗪治疗慢性阻塞性肺疾病肺动脉高压的临床研究[J].现代医学,2009,37(2):126-128. 被引量:11

二级参考文献38

  • 1荆志成,胡大一.肺动脉高压康复指南[M].3版.北京:人民军医出版社,2006:3.
  • 2Nishimura T , Vaszar L T, Faul J L, et al. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells [ J], Circulation, 2003, 108 (13) :1640-1645.
  • 3Kao P N. Simvastatin treatment of pulmonary hypertension:an observational case series [ J ]. Chest,2005,127 (4) : 1446-1452.
  • 4Weis M, Heeschen C, Glassford A J, et al. Statins have bi-phasic effects on angiogenesis [ J ]. Circulation, 2002,105 ( 6 ) : 739-745.
  • 5Martinez-Gonzalez J, Escudero I, Badimon L. Simvastatinpotenciates PGI (2) release induced by HDL in human VSMC : effect on Cox2 upregulation and MAPK signal ling pathways activated by HDL [ J ]. Atherosclerosis, 2004,174 ( 2 ) : 305- 313.
  • 6蔡柏蔷.呼吸内科学[M].北京:中国协和医科大学出版社,2000.812.
  • 7Tuder RM, Groves B,Badesch DB, et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension[J]. Am J Pathol, 1994,144 : 275-285.
  • 8Turner NA, O Regan D J, Ball SG, et al. Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing M MP-9 mRNA levels [J]. FASEB J, 2005,19 ( 7 ) : 804-806.
  • 9Bourcier T,Libby P. HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells[J]. Arterioscler Thromb Vasc Biol, 2000,20 ( 2 ) : 556 -562.
  • 10Wassmann S, Laufs U, Baumer AT, et al. Inhibition of geranylgeranylation reduces angiotensin Ⅱ-mediated free radical production in vascular smooth muscle cells:involvement of angiotensin AT1 receptor expression and Racl GTPase[ J]. Mol Pharmacol,2001,59:646-654.

共引文献78

同被引文献22

  • 1曹春水,黄亮.复方丹参对早期急性肺损伤炎性介质的影响[J].江西医药,2007,42(3):208-211. 被引量:14
  • 2SIMONNEAU G, GATZOULIS M A, ADATIA I, et al. Updated clinical classification of pulmonary hypertension [J]. J Am Coll Cardiol, 2013, 62(25 Suppl): D34-D41.
  • 3HSU H H, RUAN T, KO W J, et al. Effects of simvastatin on pulmonary C-fiber sensitivity in rats with monocrotaline- induced pulmonary hypertension [J]. J Heart Lung Transplant, 2011, 30(3): 332-340.
  • 4GAO Y F, ZHU X D, SHI D M, et al. The effects of atorvastatin on pulmonary arterial hypertension and expression of p38, p27, and Jab1 in rats[J]. Int J Mol Med, 2010, 26(4): 541-547.
  • 5DEMARCO V G, HABIBI J, WHALEY-CONNELL A T, et al. Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2) 27 rat[J]. Am J Physiol Heart Circ Physiol, 2009, 297(3) : H1128-H1139.
  • 6LEE T M, CHEN C C, SHEN H N, et al. Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension [J]. Clin Sci (Lond), 2009, 116(6): 497-505.
  • 7WILKINS M R, ALI O, BRADLOW W, et al. Simvastatin as a treatment for pulmonary hypertension trial[J]. Am J Respir Crit Care Med, 2010, 181(10): 1106-1113.
  • 8KAWUT S M, BAGIELLA E, LEDERER D J, et al. Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT [ J ].Circulation, 2011, 123(25): 2985-2993.
  • 9ZENG W J, XIONG C M, ZHAO L, et al. Atorvastatin in pulmonary arterial hypertension (APATH) study[J]. Eur Respir J, 5012, 40(1): 67-74.
  • 10HUMBERT M, SITBON O, SIMONNEAU G. Treatment of pulmonary arterial hypertension [J]. N Engl J Med, 2004, 351(14): 1425-1436.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部